MammoCATTM DM and DBT

null

MammoCAT™ is based on our proprietary slot scanning technology. This produces images of significantly higher contrast and resolution (up to 25 microns) and almost eliminates scattered radiation without using a scatter removal grid. Today’s Full Field Digital Mammography (FFDM) mammography systems use grids to remove scatter and therefore require higher X-ray doses to get acceptable images. MammoCAT™ DM, our first product, will provide superior FFDM images and can be upgraded in the field to our second product, MammoCAT™ DBT, that will rival Digital Breast Tomosynthesis systems currently on the market.  Our proprietary technology gives our DBT product the same advantages that it provides to MammoCAT™ DM.

The MammoCAT™ technology platform affords superior image quality, low dose and patient comfort all in one system. Cost-effectiveness is also what separates the MammoCAT™ from all current mammography systems now in clinical use.

The MammoCAT™ DM and DBT products are currently under development and are not available for sale at this time.

The MammoCATTM 2D will share the same gantry as MammoCATTM 3D, our subsequent prone system.

The MammoCATTM 2D affords superior image quality, with low dose, in one system. Cost-effectiveness is also what separates the MammoCATTM2D from all current mammography systems now in clinical use.

The MammoCATTM 2D is currently under development. The system is not available for sale at this time.

For over 100 years the Fischer name has been synonymous with quality diagnostic imaging and innovation. The new MammoCAT TM product family continues the legacy.

MammoCATTM CT

null

Our third product, MammoCAT™ CT breast scanner system, will improve the accuracy of breast cancer screening.

  • True 3D Computed Tomography imaging
  • Radiation doses equivalent to those in current FFDM systems
  • Elimination of breast compression during screening

MammoCAT™ CT will use the same imaging gantry as our DM and DBT products and allow stereotactic biopsy. All of these features, combined with the low dose, high resolution imaging will make it suitable for screening, diagnosis, staging and biopsy on the same system. This multi-purpose use will improve equipment utilization, hospital workflow and reduce demands on space.

The MammoCATTM CT product is currently under development and is not available for sale at this time.